-
1 month ago | 
medium.com | Joao Ferreira |João Pedro Ferreira
João Ferreira·Follow4 min read·--Portugal has firmly established itself as a coveted destination for affluent expats, entrepreneurs, skilled professionals, and international investors. The country’s luxury real estate market is flourishing, driven by its breathtaking coastline, vibrant culture, world-class infrastructure, and an enviable lifestyle that combines sophistication with relative affordability. The allure of Portugal as a property hotspot is undeniable.
-
1 month ago | 
medium.com | Joao Ferreira |João Pedro Ferreira
João Ferreira·Follow4 min read·--Portugal has long been a favourite destination for expats and investors, and the latest Wealthy Expats in Portugal Survey Report 2025 confirms its continued dominance as a top global relocation destination. Published by World Digital Foundation Research, this independent report provides valuable insights into why affluent expats are choosing Portugal.
-
Jan 13, 2025 | 
techtudo.com.br | Joao Ferreira
A melhor sensibilidade no Valorant oferece velocidade e precisão dos jogadores. Para isso, é muito importante encontrar o equilíbrio para subir de elo no FPS tático da Riot Games, além de conseguir se sair bem contra os oponentes no jogo. Alguns recursos como o aumento da porcentagem de headshots e a rapidez para atingir os inimigos no momento de "trocação" dos tiros são pontos fundamentais que podem ser melhorados a partir de uma boa configuração da sensi.
-
Jan 9, 2025 | 
techtudo.com.br | Joao Ferreira
A Nvidia anunciou na última terça-feira (7) o Project Digits, novo computador de Inteligência Artificial (IA) da fabricante de chips. O modelo foi divulgado durante a CES 2025, a maior feira de eletrônicos do mundo, que acontece em Las Vegas, Estados Unidos, e deve chegar ao mercado no mês de maio, com valor na casa de US$ 3.000 (cerca de R$ 18.310,800 na cotação atual do dólar).
-
Sep 5, 2024 | 
nature.com | Fang-Fei Wei |Pierpaolo Pellicori |Joao Ferreira |Arantxa González |De-Wei An |Chen Liu | +10 more
AbstractNone of the spironolactone trials in heart failure (HF) assessed the blood pressure (BP) responses to exercise, while conflicting results were reported for exercise capacity. In the HOMAGE trial, 527 patients at increased HF risk were randomized to usual treatment with or without spironolactone (25–50 mg/day). The current substudy included 113 controls and 114 patients assigned spironolactone, who all completed the incremental shuttle walk test at baseline and months 1 and 9.
-
Aug 14, 2024 | 
onlinelibrary.wiley.com | Joao Ferreira |Adriaan A. Voors
Letter to the Editor Reply to ‘Empagliflozin and glucagon-like peptide-1 receptor agonists: The brothers for heart failure?’ João Pedro Ferreira, Corresponding Author João Pedro Ferreira UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal Corresponding author. Email: [email protected] for more papers by this authorAdriaan A. Voors, Adriaan A.
-
Jul 9, 2024 | 
onlinelibrary.wiley.com | Joao Ferreira |Jonathan Blatchford |John R. Teerlink |Mikhail Kosiborod
Supporting Information Filename Description ejhf369-sup-0001-FigureS1.docxWord 2007 document , 365.2 KB Appendix S1. Supporting Information. References 1, , , , , , et al. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: A multinational randomized trial. Nat Med 2022; 28: 568–574. https://doi.org/10.1038/s41591-021-01659-1 2, , , , , , et al. Impact of empagliflozin on decongestion in acute heart failure: The EMPULSE trial.
-
Jul 1, 2024 | 
jacc.org | Milton Packer |Joao Ferreira |Javed Butler |Gerasimos Filippatos
IntroductionSodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular death and hospitalization for heart failure in patients with heart failure, both with reduced and preserved ejection fraction.1 Potential mechanisms of action have been elucidated in both experimental models and in the clinical setting.
-
May 13, 2024 | 
dialnet.unirioja.es | Joao Ferreira |Christa Court |Lori Pennington-Gray |Joao Pedro
João-Pedro Ferreira[2][3];Christa D. Court[3];Estefania Basurto-Cedeño[4][1];Lori Pennington-Gray[4][1]Universidad Laica Eloy Alfaro de Manabí[2]University of Virginia, Charlottesville, VA, USA[3]University of Florida, Gainesville, FL, USA[4]University of South Carolina, Columbia, SC, USALocalización: Tourism economics: the business and finance of tourism and recreation, ISSN 1354-8166, Vol. 30, Nº. Extra 4, 2024 (Ejemplar dedicado a: IATE 2022 Conference), págs.
-
May 3, 2024 | 
dialnet.unirioja.es | John Gregson |Joao Ferreira |Tim Collier |Joao Pedro
winratiotest: A command for implementing the win ratio and stratified win ratio in StataAutores: John Gregson, João Pedro Ferreira, Tim CollierLocalización: The Stata journal, ISSN 1536-867X, Vol. 23, Nº. 3, 2023, págs. 835-850Idioma: inglésEnlacesTexto completoResumenThe win ratio is a statistical method most commonly used for ana- lyzing composite outcomes in clinical trials.
